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ABSTRACT
Introduction: Hypertension is a major risk factor for
cardiovascular diseases. In adults, high sodium intake
is associated with elevated blood pressure. In
children, experimental studies have shown that
reducing sodium intake can reduce blood pressure.
However, their external validity is limited, notably
because the sodium reduction was substantial and not
applicable in a real-life setting. Observational studies,
on the other hand, allow assess the association
between blood pressure and sodium intake across
usual levels of consumption. There is also evidence
that the association differs between subgroups of
children according to age and body weight. Our
objective is to conduct a systematic review and meta-
analysis of experimental and observational studies on
the association between sodium intake and blood
pressure in children and adolescents and to assess
whether the association differs according to age and
body weight.
Methods and analysis: A systematic search of the
MEDLINE, EMBASE, CINAHL and CENTRAL databases
will be conducted and supplemented by a manual
search of bibliographies and unpublished studies.
Experimental and observational studies involving
children or adolescents between 0 and 18 years of
age will be included. The exposure will be dietary
sodium intake, estimated using different methods
including urinary sodium excretion. The outcomes will
be systolic and diastolic blood pressure, elevated
blood pressure and hypertension. If appropriate, meta-
analyses will be performed by pooling data across all
studies together and separately for experimental and
observational studies. Subgroup meta-analyses by age
and body weight will be also conducted. Moreover,
separate meta-analyses for different sodium intake
levels will be conducted to investigate the dose–
response relationship.
Ethics and dissemination: This systematic review
and meta-analysis will be published in a peer-reviewed
journal. A report will be prepared for national
authorities and other stakeholders in the domains of
nutrition, public health, and child health in
Switzerland.
Trial registration number: CRD42016038245.
INTRODUCTION
Rationale
Hypertension is a major modiﬁable risk
factor for cardiovascular diseases and a
major cause of morbidity and mortality
worldwide.1–3 There is also growing evidence
that elevated blood pressure has its roots
early in life and that blood pressure tracks
from childhood to adulthood.4–7 Further,
intermediate markers of hypertensive target
organ damage, such as left ventricular hyper-
trophy and thickening of the carotid artery
vessel wall, have been found in children and
adolescents with elevated blood pressure.6 7
This suggests that early life interventions
aiming at the primordial prevention of ele-
vated blood pressure could help prevent life-
long hypertension and its associated
consequences.8 9
Numerous studies indicate that high
sodium intake is a cause of elevated blood
Strengths and limitations of this study
▪ This systematic review and meta-analysis will
contribute to strengthen our knowledge on the
effect of sodium intake on blood pressure in chil-
dren and adolescents.
▪ It will be the first systematic review on this
subject to include observational studies in add-
ition to experimental studies.
▪ We will carry out a critical review of the method-
ology of the studies included.
▪ We will investigate whether the association
between sodium intake and blood pressure in
children differs according to age and body
weight. Separate meta-analyses for different
sodium intake levels will be also conducted to
investigate the dose–response relationship.
▪ This protocol has been written following the
Preferred Reporting Items for Systematic review
and Meta-Analysis Protocols (PRISMA-P) guide-
lines and has been registered in PROSPERO.
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pressure in adults.10 11 For children and adolescents,
much less evidence is available and ﬁndings are equivo-
cal. Hence, while some observational studies have shown
a positive association between high sodium intake and
elevated blood pressure in children,12–16 others have
not.17–20 Meta-analyses of experimental studies con-
cluded that the reduction of sodium intake can lower
blood pressure in children.21 22 Their external validity is,
however, limited because the sodium reduction in these
trials was often substantial and likely not applicable in a
real-life setting, where only modest reductions are feas-
ible on the long run. Based on the results of experimen-
tal studies, it is therefore difﬁcult to make
recommendations applicable to the whole population.
There is also evidence that some groups of children
have different salt sensitivity for blood pressure depend-
ing notably on age, birth weight, prematurity or body
weight.12 23 The heterogeneity in the effect of sodium
intake on blood pressure in subgroups of children has
not been considered in previous reviews and
meta-analyses.
Including observational studies has been recom-
mended to overcome some limitations of meta-analyses
of experimental studies, notably to increase external val-
idity.24 Furthermore, data from observational studies
would permit the assessment of the association between
blood pressure and sodium intake across usual levels of
consumption, as well as the determination of the shape
of the association. This would also permit accounting
for differences in salt sensitivity of blood pressure
between various subgroups of children, in particular,
according to age and body weight.
Objectives
Our primary objective is to conduct a systematic review
and meta-analysis of experimental and observational
studies assessing the association between sodium intake
and blood pressure in children and adolescents. Our
secondary objective is to assess whether this association
differs according to age and body weight.
METHODS AND ANALYSIS
The protocol has been developed following the PRISMA
statement for preferred reporting items for systematic
reviews and meta-analysis protocols,25–27 the
Meta-analysis Of Observational Studies in Epidemiology
(MOOSE) guidelines28 and the Cochrane handbook for
Systematic Reviews of Interventions.29 This systematic
review has been registered with the International
Prospective Register of Systematic Reviews (PROSPERO)
(registration number CRD42016038245).
Eligibility criteria
Study designs
This systematic review will include experimental and
observational studies. The following study designs will be
included: randomised and non-randomised controlled
and non-controlled trials, clinical trials,
quasi-experimental studies, case–control, cohort and
cross-sectional studies. Ecological studies, case series,
case reports, reviews, meta-analyses, policy papers, com-
ments, congress proceedings and animal studies will not
be included.
Participants
Studies involving children or adolescents between 0 and
18 years of age, irrespective of sex, weight and hyperten-
sion status, will be included. Studies involving children
and adults will be included only if the data for children
can be extracted separately.
Interventions and exposure
For experimental studies, the intervention will be
change in sodium intake. For observational studies, the
exposure of interest will be the level of sodium intake.
Methods of measurement of sodium intake will include
dietary assessment of sodium intake (based on, eg,
24-hour recall or semi-quantitative food frequency ques-
tionnaires) and urinary sodium excretion (based on
24-hour urine collection or spot urine samples).
Experimental studies with a pharmacologic intervention
(ie, antihypertensive drugs or other related medication)
will be excluded.
Outcome measures
The outcomes will be systolic and diastolic blood pres-
sure, elevated blood pressure and hypertension.
Timing
There will be no restriction by duration of intervention
or by length of follow-up.
Setting and language
There will be no restriction by type of setting. Studies in
English, French, German or Spanish will be included.
Search strategy
A systematic search of the following electronic databases
will be conducted:
▸ Medical Literature Analysis and Retrieval System
Online (MEDLINE) by the USA National Library of
Medicine (NLM) via PubMed from 1946 to present;
▸ Cumulative Index to Nursing and Allied Health
Literature (CINAHL) via EBSCO from 1961 to
present;
▸ Excerpta Medica database (EMBASE) by Elsevier
from 1947 to present;
▸ Cochrane Central Register of Controlled Trials
(CENTRAL) from 1974 to present.
The search strategies were developed with the help of
an experienced librarian. The search strategy for
MEDLINE was developed ﬁrst (see box 1) and then
adapted for CINAHL, EMBASE and CENTRAL (see
online supplementary material ﬁles for the detailed
search strategies for each databases). Three concepts
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were deﬁned to determine the key terms of the search
and their related terms: (1) children (related terms:
baby, neonate, newborn, infant, toddler, preschool child,
school child, pupil, student, boy, girl, adolescent, teen-
ager), (2) sodium intake (related terms: salt, sodium
chloride, diet, consumption, restriction, reduction,
urinary sodium excretion, sodium in urine) and (3)
blood pressure (related terms: arterial pressure, systolic
pressure, diastolic pressure, hypertension, high blood
pressure, elevated blood pressure). The database
searches will use text terms and indexing terms from the
thesaurus of the databases (ie, Medical Subject
Headings (MeSH) for MEDLINE, CINAHL, and
CENTRAL, and Emtree for EMBASE), Boolean opera-
tors and truncations.
In addition to the database search, a manual search of
all the bibliographies of the retrieved articles and other
reviews on the same topic will be conducted to identify
additional studies. The literature search will be supple-
mented by a search in Web of Science and Google
Scholar. Moreover, the following clinical trial registers
will be searched to identify studies of interest not yet
published: International Clinical Trials Registry Platform
registry (http://www.isrctn.com); the USA’ ClinicalTrials.
gov (http://www.clinicaltrials.gov) and the EU Clinical
Trials Register (http://www.clinicaltrialsregister.eu). To
access the results from completed trials found in these
trial registers which do not have published reports, the
principal investigators of the studies of interest will be
contacted by email. A maximum of three email attempts
will be conducted, after which efforts to access results
will be abandoned.
Study selection
After the collection of all the potential articles, dupli-
cates will be removed. If multiple publications are found
to originate from one single study, the results of that
study will be collated into one.
All the articles retrieved will be examined by two inde-
pendent reviewers (ML and ACha). As a ﬁrst step, each
reviewer will screen the titles and abstracts and retain
articles following the eligibility criteria mentioned
above. As a second step, each reviewer will further assess
the eligibility of each article retained after the ﬁrst step
by reviewing the full text article. A detailed record of
the reasons for excluding studies will be kept. A data
management software, Covidence (Covidence systematic
review software, Veritas Health Innovation, Melbourne,
Australia; www.covidence.org), will be used to organise
the review and selection of articles.
Any disagreement on the exclusion or inclusion of an
article between the two reviewers will be resolved by dis-
cussion or, if necessary, by a third reviewer (AChi).
Data extraction
The two reviewers will independently extract data from
each included study using Microsoft Ofﬁce Excel 2007.
The following information will be extracted:
1. Study identiﬁcation: authors, year of publication,
journal, funding or sponsorship;
2. Study characteristics: country where the study was
conducted, year when study was conducted, study
type (observational or experimental), study design
(randomised controlled study, controlled study,
cohort study, cross-sectional study, etc), sampling
method, sample size (total, per group and at differ-
ent time points), study setting, study duration or
follow-up period, participation rates and any other
study characteristics;
3. Population characteristics: age, sex, weight, height,
body mass index (BMI), blood pressure, hyperten-
sion status and treatment, ethnicity and other
characteristics (eg, birth weight, prematurity,
diabetes);
4. Exposure or intervention: for all studies, sodium
intake for experimental studies, detailed information
on the type and duration of the intervention will be
recorded (eg, education, individual counselling,
Box 1 Search strategy for MEDLINE (MeSH, Medical
Subject Headings)
1. baby[Text Word]
2. neonat*[Text Word]
3. newborn*[Text Word] OR “infant, newborn”[MeSH Terms]
4. infan*[Text Word] OR infant[MeSH Terms]
5. toddler*[Text Word]
6. child*[Text Word] OR child[MeSH Terms]
7. preschool[Text Word] OR “child, preschool”[MeSH Terms]
8. school[Text Word]
9. pupil*[Text Word] OR pupil[MeSH Terms]
10. student*[Text Word]
11. boy*[Text Word]
12. girl*[Text Word]
13. adolescen*”[Text Word] OR adolescent[MeSH Terms]
14. teenage*[Text Word]
15. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR
11 OR 12 OR 13 OR 14
16. diet*[Text Word] OR diet[MeSH Terms] OR intake*[Text
Word] OR consum*[Text Word] OR restric*[Text Word] OR
reduc*[Text Word]
17. salt[Text Word] AND 16
18. sodium[Text Word] AND 16
19. “sodium, dietary”[MeSH Terms]
20. “sodium chloride, dietary”[MeSH Terms]
21. “diet, sodium restricted”[MeSH Terms]
22. “urinary sodium excretion”[Text Word]
23. “sodium/urine*"[MeSH Terms]
24. 17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23
25. “blood pressure”[Text Word] OR “blood pressure”[MeSH
Terms]
26. “diastolic”[Text Word]
27. “systolic”[Text Word]
28. “arterial”[Text Word] OR “arterial pressure”[MeSH Terms]
29. hypertension[Text Word] OR hypertension[MeSH Terms]
30. 25 OR 26 OR 27 OR 28 OR 29
31. 15 AND 24 AND 30
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cooking demonstrations, reduction of foods with
high sodium, low sodium bread, low sodium drinking
water, low sodium school meals, low sodium infant
formula, diet high in fruits and vegetables, etc);
5. Sodium intake measurement method: dietary intake
assessment method (eg, 24-hour recall or semi-
quantitative food frequency questionnaire, validated
questionnaire or not), urine collection method (eg,
spot test, single or repeated 24-hour urine collec-
tion), number of measurements, training of persons
doing the measurement, etc;
6. Outcome: systolic and diastolic blood pressure, ele-
vated blood pressure and hypertension;
7. Outcome measurement method: that is, auscultatory
versus oscillometry, type of blood pressure measure-
ment device, ofﬁce versus home versus ambulatory
measurement, number of visits, number of measure-
ments per visit, training of persons doing the measure-
ments, use of a standardised protocol, cuff size, etc;
8. Potential confounding and effect modiﬁcation
factors: if available, information on potential con-
founding factors, for example, body weight, potas-
sium and calcium intakes, and potential effect
modiﬁcation factors, for example, age, body weight,
sex and ethnicity, will be recorded. Any adjustment
for these variables will be documented and consid-
ered when conducting the meta-analyses.
Study quality
Information on the data quality will be extracted for all
studies according to the four criteria outlined in table 1.
Further, for experimental studies, an additional assess-
ment of the data quality will be done according to the
Cochrane collaboration’s risk of bias tool.29 For observa-
tional studies, the data quality will also be assessed
according to the Newcastle-Ottawa Scale for non-
randomised studies.30
If essential information on the study is missing, the
corresponding author of the article will be contacted by
email to obtain the missing information (maximum of
three email attempts). Any disagreement on the
extracted data and data quality assessments between the
two reviewers will be resolved by discussion or, if neces-
sary, with a third reviewer.
Data analyses
The statistical analyses will be conducted with RStudio
(V.0.99.473), Stata (V.14.1) and RevMan (V.5.3) (Review
Manager (RevMan) [Computer program]. 5.3 version.
Copenhagen: The Nordic Cochrane Centre, 2014).
Measures of effect or association
For the experimental studies, the measure of effect for
continuous outcomes will be deﬁned as the difference
in means of blood pressure levels between the interven-
tion and the control group. For dichotomous outcomes,
that is, elevated blood pressure and hypertension, the
measure of effect will be the OR or the relative risk. If
data are available at multiple time points, the time
points nearest to the beginning and the end of the inter-
vention will be selected.
For the observational studies, the measure of associ-
ation for continuous outcomes will be the correlation
(or regression coefﬁcient) between sodium intake and
blood pressure. For dichotomous outcomes, the OR at
different sodium intake ranges will be used as the main
measure of association.
The different measures of exposure and outcome, and
the corresponding measures of effect and association,
will be converted into sodium intakes in grams per day,
Table 1 Criteria for assessing data quality
Quality
level Criteria
Method for exposure measurement
High Urinary sodium excretion by 24-hour urine collection and high quality of urine collection
Low Urine spot test or questionnaire
Unclear Insufficient information to permit judgement
Method and setting for measurement of outcome
High Measured multiple times, by trained professional and using standardised procedures. If measured by
oscillometric method, the device is clinically validated.
Low Otherwise (if not all criteria mentioned above are met)
Unclear Insufficient information to permit judgement
External validity
High Characteristics of study population are relatively representative of, and generalizable to, the general population
Low Characteristics of study population are present in only a specific part of the population (eg, hypertensive
children, obese children, etc)
Unclear Insufficient information to permit judgement
Reporting
High Complete report and if applicable trial registration
Low Incomplete report (eg, not all prespecific primary outcomes are reported), source of financial support is missing
or impartial
Unclear Insufficient information to permit judgement
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systolic and diastolic blood pressure levels in mm Hg,
and prevalence of elevated blood pressure and hyperten-
sion in percentage. If the sodium intake is available in
ranges only, the midpoint of the range will be taken.
Meta-analyses
It is anticipated that there will be a sufﬁcient number of
studies to conduct meta-analyses. In brief, meta-analyses
will be performed by pooling data across all studies
together and separately for experimental and observa-
tional studies. Subgroup meta-analyses by age and body
weight will be also conducted to evaluate whether the
association between sodium intake and blood pressure
differs (1) between younger and older children and (2)
between normal weight and overweight/obese children.
Random effect analyses will be performed, as heterogen-
eity in the effect size estimate between studies is expected.
Forest plots will be used to present the results graphically. To
better express uncertainties in the effect estimates, 95% pre-
diction intervals will be computed.31 32 If study results are
reported in a format that cannot be converted to a standard
metric, they will be summarised in a narrative format.
Dose–response relationship
The relation between sodium intake and blood pressure
has been hypothesised to be linear and more recently j-
shaped.33 The dose–response relationship between
sodium intake and blood pressure will be investigated by
conducting separate meta-analyses for incremental levels
of sodium intakes. Various models, that is, linear and
polynomial, will be investigated and ﬁtted to the col-
lected data. If sufﬁcient data are available, this analysis
will be stratiﬁed by age and body weight.
Assessment of heterogeneity
The heterogeneity will be assessed by the I2 statistic and
between-study variance σ2. Sources of heterogeneity will be
explored using subgroup analyses and meta-regression,29 if
sufﬁcient studies are included, based on the following vari-
ables: study design, study or intervention duration, sample
size, adjustments made, sodium intake ranges and meas-
urement methods, blood pressure measurement methods,
potassium intake, calcium intake, age, sex and weight.
Sensitivity analyses will be performed (1) excluding rela-
tively small studies, (2) restricting analyses to studies of
high quality and (3) restricting analyses to studies using
24-hour urine collection to assess sodium intake.
Assessment of publication bias
Publication bias will be evaluated by enhanced funnel
plots and Egger’s test.29 34
Assessment of strength of evidence
The strength of the body of evidence for this systematic
review (ie, for the ensemble of all the studies included
in the review) will be assessed using The Grading of
Recommendations, Assessment, Development and
Evaluation (GRADE) framework.35
ETHICS AND DISSEMINATION
The results of this systematic review will summarise the
current state of evidence for the association between
sodium intake and blood pressure in children. The
results of this systematic review will be critically inter-
preted and discussed in light of the quality of the studies
included. Moreover, it will broaden the results of previ-
ous reviews, notably by the potential identiﬁcation of
subgroups of children highly sensitive to sodium intake
and for which targeted intervention aiming at reducing
of sodium intake could be justiﬁed.
This systematic review will be reported according to
the recommendations of the PRISMA statement.27 The
results will be disseminated via the publication of one or
more manuscripts in a peer-reviewed journal and the
presentation at one or more conferences. Moreover, a
report will be prepared for the Swiss Federal Food Safety
and Veterinary Ofﬁce and for other stakeholders in the
domains of nutrition, public health and child health in
Switzerland. This report will present the results and will
discuss the implications of the ﬁndings in general and
more speciﬁcally for Switzerland.
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